Report Detail
Global Recombinant Vector Vaccines Market Growth 2019-2024
- RnM3161122 |
- 22 March, 2019 |
- Global |
- 159 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Recombinant vector vaccines are experimental vaccines similar to DNA vaccines, but they use an attenuated virus or bacterium to introduce microbial DNA to cells of the body. “Vector” refers to the virus or bacterium used as the carrier.
In nature, viruses latch on to cells and inject their genetic material into them. In the lab, scientists have taken advantage of this process. They have figured out how to take the roomy genomes of certain harmless or attenuated viruses and insert portions of the genetic material from other microbes into them. The carrier viruses then ferry that microbial DNA to cells. Recombinant vector vaccines closely mimic a natural infection and therefore do a good job of stimulating the immune system.
Attenuated bacteria also can be used as vectors. In this case, the inserted genetic material causes the bacteria to display the antigens of other microbes on its surface. In effect, the harmless bacterium mimics a harmful microbe, provoking an immune response.
Researchers are working on both bacteria-l and viral-based recombinant vector vaccines for HIV, rabies, and measles.
According to this study, over the next five years the Recombinant Vector Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Recombinant Vector Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Vector Vaccines market by product type, application, key manufacturers and key regions and countries.
This study considers the Recombinant Vector Vaccines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
For Adult
For Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
SANOFI PASTEUR S.A.
Novartis
GSK
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Recombinant Vector Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Recombinant Vector Vaccines market by identifying its various subsegments.
Focuses on the key global Recombinant Vector Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Recombinant Vector Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Recombinant Vector Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Recombinant Vector Vaccines Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Recombinant Vector Vaccines Consumption 2014-2024
- 2.1.2 Recombinant Vector Vaccines Consumption CAGR by Region
- 2.2 Recombinant Vector Vaccines Segment by Type
- 2.2.1 Varicella
- 2.2.2 Influenza
- 2.2.3 Polio
- 2.2.4 Hepatitis A
- 2.2.5 Rabies
- 2.2.6 BCG
- 2.2.7 Hepatitis B
- 2.2.8 Pertussis, Diphtheria, tetanus
- 2.2.9 Pneumococcal
- 2.2.10 Others
- 2.3 Recombinant Vector Vaccines Consumption by Type
- 2.3.1 Global Recombinant Vector Vaccines Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Recombinant Vector Vaccines Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Recombinant Vector Vaccines Sale Price by Type (2014-2019)
- 2.4 Recombinant Vector Vaccines Segment by Application
- 2.4.1 For Adult
- 2.4.2 For Child
- 2.5 Recombinant Vector Vaccines Consumption by Application
- 2.5.1 Global Recombinant Vector Vaccines Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Recombinant Vector Vaccines Value and Market Share by Application (2014-2019)
- 2.5.3 Global Recombinant Vector Vaccines Sale Price by Application (2014-2019)
3 Global Recombinant Vector Vaccines by Players
- 3.1 Global Recombinant Vector Vaccines Sales Market Share by Players
- 3.1.1 Global Recombinant Vector Vaccines Sales by Players (2017-2019)
- 3.1.2 Global Recombinant Vector Vaccines Sales Market Share by Players (2017-2019)
- 3.2 Global Recombinant Vector Vaccines Revenue Market Share by Players
- 3.2.1 Global Recombinant Vector Vaccines Revenue by Players (2017-2019)
- 3.2.2 Global Recombinant Vector Vaccines Revenue Market Share by Players (2017-2019)
- 3.3 Global Recombinant Vector Vaccines Sale Price by Players
- 3.4 Global Recombinant Vector Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Recombinant Vector Vaccines Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Recombinant Vector Vaccines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Recombinant Vector Vaccines by Regions
- 4.1 Recombinant Vector Vaccines by Regions
- 4.1.1 Global Recombinant Vector Vaccines Consumption by Regions
- 4.1.2 Global Recombinant Vector Vaccines Value by Regions
- 4.2 Americas Recombinant Vector Vaccines Consumption Growth
- 4.3 APAC Recombinant Vector Vaccines Consumption Growth
- 4.4 Europe Recombinant Vector Vaccines Consumption Growth
- 4.5 Middle East & Africa Recombinant Vector Vaccines Consumption Growth
5 Americas
- 5.1 Americas Recombinant Vector Vaccines Consumption by Countries
- 5.1.1 Americas Recombinant Vector Vaccines Consumption by Countries (2014-2019)
- 5.1.2 Americas Recombinant Vector Vaccines Value by Countries (2014-2019)
- 5.2 Americas Recombinant Vector Vaccines Consumption by Type
- 5.3 Americas Recombinant Vector Vaccines Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Recombinant Vector Vaccines Consumption by Countries
- 6.1.1 APAC Recombinant Vector Vaccines Consumption by Countries (2014-2019)
- 6.1.2 APAC Recombinant Vector Vaccines Value by Countries (2014-2019)
- 6.2 APAC Recombinant Vector Vaccines Consumption by Type
- 6.3 APAC Recombinant Vector Vaccines Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Recombinant Vector Vaccines by Countries
- 7.1.1 Europe Recombinant Vector Vaccines Consumption by Countries (2014-2019)
- 7.1.2 Europe Recombinant Vector Vaccines Value by Countries (2014-2019)
- 7.2 Europe Recombinant Vector Vaccines Consumption by Type
- 7.3 Europe Recombinant Vector Vaccines Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Recombinant Vector Vaccines by Countries
- 8.1.1 Middle East & Africa Recombinant Vector Vaccines Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Recombinant Vector Vaccines Value by Countries (2014-2019)
- 8.2 Middle East & Africa Recombinant Vector Vaccines Consumption by Type
- 8.3 Middle East & Africa Recombinant Vector Vaccines Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Recombinant Vector Vaccines Distributors
- 10.3 Recombinant Vector Vaccines Customer
11 Global Recombinant Vector Vaccines Market Forecast
- 11.1 Global Recombinant Vector Vaccines Consumption Forecast (2019-2024)
- 11.2 Global Recombinant Vector Vaccines Forecast by Regions
- 11.2.1 Global Recombinant Vector Vaccines Forecast by Regions (2019-2024)
- 11.2.2 Global Recombinant Vector Vaccines Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Recombinant Vector Vaccines Forecast by Type
- 11.8 Global Recombinant Vector Vaccines Forecast by Application
12 Key Players Analysis
- 12.1 SANOFI PASTEUR S.A.
- 12.1.1 Company Details
- 12.1.2 Recombinant Vector Vaccines Product Offered
- 12.1.3 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 SANOFI PASTEUR S.A. News
- 12.2 Novartis
- 12.2.1 Company Details
- 12.2.2 Recombinant Vector Vaccines Product Offered
- 12.2.3 Novartis Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Novartis News
- 12.3 GSK
- 12.3.1 Company Details
- 12.3.2 Recombinant Vector Vaccines Product Offered
- 12.3.3 GSK Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 GSK News
- 12.4 CNBG
- 12.4.1 Company Details
- 12.4.2 Recombinant Vector Vaccines Product Offered
- 12.4.3 CNBG Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 CNBG News
- 12.5 ChengDa Bio
- 12.5.1 Company Details
- 12.5.2 Recombinant Vector Vaccines Product Offered
- 12.5.3 ChengDa Bio Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 ChengDa Bio News
- 12.6 Changsheng Life
- 12.6.1 Company Details
- 12.6.2 Recombinant Vector Vaccines Product Offered
- 12.6.3 Changsheng Life Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Changsheng Life News
- 12.7 Zhifei
- 12.7.1 Company Details
- 12.7.2 Recombinant Vector Vaccines Product Offered
- 12.7.3 Zhifei Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Zhifei News
- 12.8 SINOVAC BIOTECH
- 12.8.1 Company Details
- 12.8.2 Recombinant Vector Vaccines Product Offered
- 12.8.3 SINOVAC BIOTECH Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 SINOVAC BIOTECH News
- 12.9 NuoCheng Bio
- 12.9.1 Company Details
- 12.9.2 Recombinant Vector Vaccines Product Offered
- 12.9.3 NuoCheng Bio Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 NuoCheng Bio News
- 12.10 Hualan Bio
- 12.10.1 Company Details
- 12.10.2 Recombinant Vector Vaccines Product Offered
- 12.10.3 Hualan Bio Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Hualan Bio News
- 12.11 Kangtai
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Recombinant Vector Vaccines . Industry analysis & Market Report on Recombinant Vector Vaccines is a syndicated market report, published as Global Recombinant Vector Vaccines Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Recombinant Vector Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
